ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Spondyloarthritis

Spondyloarthritis

©Mirana/Shutterstock.com

Axial spondyloarthritis (SpA) often goes undiagnosed and is more common than previously thought, a study shows.

@Lightspring/Shutterstock.com

The diagnosis and treatment of spondyloarthritis (axSpA) and ankylosing spondylitis (AS) for primary healthcare providers.

©Custommedia/Shutterstock.com

Researchers say it's not necessary to take high body mass index into account in axial spondyloarthritis.

©PhuShutter/Shutterstock.com

Patients with spondyloarthritis can confidently undergo treatment with tumor necrosis factor ⍺ inhibitors (TNFi) without fear of cancer risk.

©SebastianKaulitzki2/Shutterstock.com

Many new treatments for axial spondyloarthritis (SpA) have been introduced in recent years. This review summarizes current treatments for SpA.

©SutthaBurawonk/Shutterstock.com

New treatment guidelines for non-radiographic axial spondyloarthritis call for treatment with TNF blockers if NSAIDs fail.

Research highlights a need for closer partnerships between physicians and patients to set shared treatment goals.

Pages

Subscribe to Spondyloarthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.